Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,254,099
+$667,329 QoQ
Shares Held
4,620
+57.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#417
of 844 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $12,016,370 across 14 Diagnostics & Research names. NTRA ranks #3 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,917 | $3,467,907 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
1,238 | $1,581,557 | |
| 3 | NTRA |
Natera, Inc.
This page
|
4,620 | $1,254,099 | |
| 4 | DHR |
Danaher Corp /De/
|
6,373 | $1,213,929 | |
| 5 | A |
Agilent Technologies, Inc.
|
5,645 | $749,825 | |
| 6 | WAT |
Waters Corp /De/
|
1,626 | $609,815 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,847 | $550,097 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,786 | $500,080 |
All Filings in NTRA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,254,099 | 4,620 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $586,770 | 2,934 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $671,920 | 2,933 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $452,164 | 2,809 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $406,469 | 2,406 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $512,328 | 3,623 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $559,432 | 3,534 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $593,872 | 4,678 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $511,995 | 4,728 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||